Colombia’s Clínica Imbanaco Joins the TriNetX Network to Increase International Research Collaboration
Clínica Imbanaco, a leading research organization in Colombia, has joined the TriNetX network to maximize its research capacity and to expand its collaboration with other research sites around the world. Headquartered in Cali, Colombia, Clínica Imbanaco’s Research Institute has participated in 143 industry-sponsored clinical trials since its founding in 2010.
Leading Cancer Center in France, L’Institut de Cancérologie de l’Ouest (ICO), Joins the TriNetX Network to Strengthen Research Capabilities
St Herblain, France, September 27, 2021 — L'Institut de Cancérologie de l'Ouest (ICO), one of the leading provincial cancer centers in France, has joined the TriNetX global health research network to facilitate innovative patient care, promote clinical research, and...
Marshfield Clinic Research Institute Joins TriNetX to Increase Participation in High-Impact Clinical Trial Opportunities
The Marshfield Clinic Research Institute, a division of Marshfield Clinic Inc. and the largest private medical research institute in Wisconsin, has joined the TriNetX network to increase clinical trial opportunities for its largely rural patient population.
North Estonia Medical Centre Joins the TriNetX Network to Improve Collaboration with the International Research Community
The North Estonia Medical Centre, the leading teaching and research hospital in Estonia, has joined the TriNetX network to expand its collaboration efforts within the international community of research investigators and gain more visibility for the organization.
TriNetX announced today it has entered into an agreement with Takeda Pharmaceutical Company Limited (“Takeda”) to unlock the value of real-world data (RWD) and accelerate the delivery of transformative therapies to patients.
Italy’s Ospedale San Raffaele Joins the TriNetX Network to Expand its Leadership Position in Gene Therapy Research
TriNetX announces that Ospedale San Raffaele (OSR), Italy’s leading biomedical research institute and the country’s representative in the European University Hospital Alliance, has joined the TriNetX network to increase its commitment to clinical trial research and to build on its growing position as a leader in the field of gene therapy for rare diseases.